March 9 (Reuters) - Valeant Pharmaceuticals International Inc
* Valeant announces launch of private offering of senior secured notes
* Valeant - launched an offering of $2.5 billion aggregate principal amount of senior secured notes
* Valeant - offering of $2.5 billion aggregate principal amount of senior secured notes in two tranches, one of which would mature in 2022 and one in 2024
* Valeant - net proceeds of offering expected to be used to repay certain loans outstanding under company’s credit facilities
* Valeant - proceeds of offering to also be used to finance tender offer for up to $600 million of co’s outstanding 6.75% senior notes due 2018 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.